Eticovo Dosage

Adult Patients

Eticovo is administered by subcutaneous injection.

See the Eticovo (etanercept-ykro) “Instructions for Use” insert for detailed information on injection site selection and dose administration.

Pediatric Patients

Eticovo is administered by subcutaneous injection.

Note: There is no dosage form for Eticovo that allows weight base dosing for pediatric patients below 63 kg (138 pounds). To achieve pediatric doses other than 50 mg, use other reconstituted etanercept products lyophilized powder.

Doses of etanercept products higher than those described in Table 2 have not been studied in pediatric patients.

In JIA patients, glucocorticoids, NSAIDs, or analgesics may be continued during treatment with Eticovo.

Preparation of Eticovo

Eticovo is intended for use under the guidance and supervision of a physician. Patients may self-inject when deemed appropriate and if they receive medical follow-up, as necessary. Patients should not self-administer until they receive proper training in how to prepare and administer the correct dose. Administer injections subcutaneously in the thigh, abdomen or outer area of the upper arm.

The Eticovo (etanercept-ykro) “Instructions for Use” insert for each presentation contains more detailed instructions on injection site selection and the preparation of Eticovo.

Monitoring to Assess Safety

Prior to initiating Eticovo and periodically during therapy, patients should be evaluated for active tuberculosis and tested for latent infection.